[go: up one dir, main page]

AU2002342488A1 - Individualization of therapy with anesthetics - Google Patents

Individualization of therapy with anesthetics

Info

Publication number
AU2002342488A1
AU2002342488A1 AU2002342488A AU2002342488A AU2002342488A1 AU 2002342488 A1 AU2002342488 A1 AU 2002342488A1 AU 2002342488 A AU2002342488 A AU 2002342488A AU 2002342488 A AU2002342488 A AU 2002342488A AU 2002342488 A1 AU2002342488 A1 AU 2002342488A1
Authority
AU
Australia
Prior art keywords
individualization
anesthetics
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002342488A
Inventor
Brian Leyland-Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xanthus Life Sciences Inc USA
Original Assignee
XANTHUS LIFE SCIENCES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XANTHUS LIFE SCIENCES Inc filed Critical XANTHUS LIFE SCIENCES Inc
Publication of AU2002342488A1 publication Critical patent/AU2002342488A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91051—Acyltransferases other than aminoacyltransferases (general) (2.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Materials Engineering (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Microbiology (AREA)
  • Composite Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002342488A 2001-11-28 2002-11-27 Individualization of therapy with anesthetics Withdrawn AU2002342488A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33348601P 2001-11-28 2001-11-28
US60/333,486 2001-11-28
PCT/CA2002/001823 WO2003046583A2 (en) 2001-11-28 2002-11-27 Individualization of therapy with anesthetics

Publications (1)

Publication Number Publication Date
AU2002342488A1 true AU2002342488A1 (en) 2003-06-10

Family

ID=23302989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342488A Withdrawn AU2002342488A1 (en) 2001-11-28 2002-11-27 Individualization of therapy with anesthetics

Country Status (2)

Country Link
AU (1) AU2002342488A1 (en)
WO (1) WO2003046583A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223797A1 (en) 2023-04-28 2024-10-31 Institut National de la Santé et de la Recherche Médicale Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections

Also Published As

Publication number Publication date
WO2003046583A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002341931A1 (en) Patient directed therapy management
AU2002321888A1 (en) Medical needle
AU2003280262A1 (en) Individualization of therapy with anticoagulants
AU2002244568A1 (en) Individualization of therapy with antipsychotics
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2001243515A1 (en) Combination drug therapy
AU2002353739A1 (en) Therapeutic compounds
AU2002302223A1 (en) Individualization of therapy with analgesics
AUPR535101A0 (en) Novel therapeutic molecules
AU2002335667A1 (en) Modified reoviral therapy
AU2002218750A1 (en) Photoactivated drug therapy
AU2002244575A1 (en) Individualization of therapy with antidepressants
AU2002349225A1 (en) Individualization of therapy with antiviral agents
AU2002350344A1 (en) Individualization of therapy with antihistamines
AU2002257411A1 (en) Individualization of therapy with antineoplastic agents
AU2002342488A1 (en) Individualization of therapy with anesthetics
AU2002257451A1 (en) Individualization of therapy with antibiotic agents
AU2002362214A1 (en) Physical therapy device
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU6106801A (en) Trans-clitoral administration of therapy
AU2002215923A1 (en) Use of medicaments
AU2002250753A1 (en) Individualization of therapy with antiarrhythmics
AU2002333079A1 (en) Individualization of therapy with anxiolitics
AU2002249042A1 (en) Individualization of therapy with hyperlipidemia agents
AU2002339178A1 (en) Quinazoline compounds with therapeutic use

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant